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Histone acetylation
RNAiof the embryonic genome in preimplantation mouse embryos is the formation of
a chromatin-mediated transcriptionally repressive state that arises in the late two-cell embryo and becomes
more pronounced with development. In this study, we investigated expression and function of Class I histone
deacetylases (HDAC) HDAC1, HDAC2, and HDAC3 during preimplantation development. HDAC1 is likely a
major deacetylase in preimplantation embryos and its expression inversely correlates with changes in the
acetylation state of histone H4K5 during preimplantation development. RNAi-mediated reduction of HDAC1
leads to hyperacetylation of histone H4 and a developmental delay even though expression of HDAC2 and
HDAC3 is signiﬁcantly induced in Hdac1-suppresssed embryos; increased expression of p21Cip1/Waf may
contribute to the observed developmental delay. RNAi-mediated reduction of HDAC2 has no noticeable effect
on preimplantation development, suggesting that individual HDACs have distinct functions during
preimplantation development. Although RNAi-mediated targeting of Hdac3 mRNA was very efﬁcient,
maternal HDAC3 protein was stable during preimplantation development, thereby preventing an exam-
ination of its role. HDAC1 knockdown does not increase the rate of global transcription in late 2-cell embryos,
but does result in elevated levels of expression of a subset of genes; this increased expression correlates with
hyperacetylation of histone H4. Results of these experiments suggest that HDAC1 is involved in the dev-
elopment of a transcriptionally repressive state that initiates in 2-cell embryos.
© 2008 Elsevier Inc. All rights reserved.IntroductionA fundamental problem in early mouse development is transform-
ing the highly differentiated oocyte into totipotent blastomeres by the
2-cell stage. This transition, which is called the maternal-to-zygotic
transition, ﬁrst entails degradation of maternal mRNAs and then
activation of the embryonic genome (Schultz, 2002). Genome activation
results not only in replacing transcripts common to the oocyte and
embryo, e.g., actin, but also in generating new transcripts and is essen-
tial for further development; mouse embryos that fail to undergo ge-
nome activation arrest at the 2-cell stage. Superimposed on genome
activation, which results in a dramatic reprogramming of gene expres-
sion, is the development of a chromatin-mediated transcriptionally
repressive state that is likely critical for generating the correct pattern of
gene expression required for continued development (Schultz, 2002).
Changes in histone acetylation likely underlie development of the
transcriptionally repressive state, because inducing histone hyper-
acetylation by using histone deacetylase (HDAC) inhibitors relieves
the enhancer requirement for efﬁcient expression of plasmid-borne
reporter genes in 2-cell embryos (Wiekowski et al., 1993; Henery et al.,iversity of Pennsylvania, 433
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l rights reserved.1995). Inducing histone hyperacetylation also relieves the repression
for endogenous genes, e.g., Eif1a (Davis et al., 1996) and results in a
further increase in global transcription as assessed by BrUTP incor-
poration (Aoki et al., 1997). Of note is that the strength of the trans-
criptionally repressive state progressively increaseswith development
(Christians et al., 1994; Henery et al., 1995).
Histone acetylation is a particularly important modiﬁcation of his-
tone amino-termini, because, in general, increased levels of histone
acetylation (hyperacetylation) are associated with transcriptionally-
permissive chromatin, whereas decreased levels of acetylation (hypo-
acetylation) are associated with repression of gene expression (Marks
et al., 2003). These changes in transcriptional activity promoted by
histone acetylation may be linked to changes in chromatin structure
(Thiagalingam et al., 2003; Peterson and Laniel, 2004; Shogren-Knaak
et al., 2006). The steady-state level of histone acetylation is controlled
by histone acetyltransferases (HATs) and histone deacetylases
(HDACs). In addition, HDACs control gene transcription by regulating
acetylation of DNA sequence-speciﬁc transcription factors (Gu and
Roeder, 1997; Wilson et al., 2006). Through these mechanisms, HDACs
are emerging as critical regulators of gene expression.
Eighteen mammalian HDACs have been identiﬁed to date (Verdin
et al., 2003). Based on their homology with yeast HDACs, the HDACs
are grouped into four classes (Bolden et al., 2006). Class I HDACs
(HDAC1, 2, 3 and 8) show homology to the yeast protein RPD3, are
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various mammalian cell lines and tissues. Class II HDACs (4,5,6,7,9 and
10) have a high degree of homology to the Hda1 protein and can
shuttle between the nucleus and the cytoplasm. Class III HDACs are
homologous to the yeast Sir2 HDAC and HDAC11 is the sole member
of the class IV HDACs. HDACs are implicated in the development
of cancer, regulation of cell proliferation, apoptosis and cell cycle
(Mehnert and Kelly, 2007). The role of individual HDACs in these
processes, however, has not been unambigously resolved, largely in
part because the physiological role of HDACs during these processes
was deduced using deacetylase inhibitors that block the majority of
class I and class II enzymes.
Transcript proﬁling suggests that oocytes and preimplantation
embryos express most Class I and II HDACs (e.g., 1,2,3,4,5,6,9, and SIR2,
and possibly HDAC7 and 11; no convincing signal is detected for
HDAC8) (Zeng et al., 2004, Zeng and Schultz, 2005; Pan et al., 2005).
Recent studies suggest that Class II HDACs (e.g., 4 and 6) are not linked
to transcription repression following genome activation (Verdel et al.,
2003; Kageyama et al., 2006). Thus, Class I HDACs may be involved in
development of the transcriptionally repressive state. Consistent with
this proposal is that microarray data reveal that only HDAC1 is
sensitive to α-amanitin among the HDACs expressed in 2-cell embryos
and Ingenuity Pathway Analysis placed HDAC1 at the hub of numerous
interactions in a gene network that could contribute to development of
the transcriptionally repressive state (Zeng and Schultz, 2005).
We report here that HDAC1 is likely to be critical for the overall
state of hyperacetylated histones in preimplantation mouse embryos
based on an inverse correlation between HDAC1 (and not HDAC2 and
3) expression and acetylation state of K5 of histone H4 (H4K5). RNAi-
mediated reduction of HDAC1 in preimplantation embryos induces
hyperacetylation of histone H4K5 despite up-regulation of HDAC2 and
3. In addition, expression of a subset of genes analyzed in HDAC1-
depleted embryos is enhanced, including genes that normally become
repressed. Development of HDAC1-depleted embryos is retarded,
perhaps due to over-expression of p21Cip1/Waf. In contrast, depleting
HDAC2 by RNAi has no effect on HDAC1 or HDAC3 protein levels,
acetylation status of H4K5, or development to the blastocyst stage.
Materials and methods
Oocyte and embryo collection, culture and microinjection
Cumulus cell-free germinal vesicle (GV)-intact oocytes were obtained from eCG-
primed CF-1 females as previously described (Schultz et al., 1983). The collection
medium for oocytes was bicarbonate-free minimal essential medium (Earle’s salts)
containing, 25 mM Hepes, pH 7.3, 3 mg/ml polyvinylpyrollidone (PVP) and 2.5 µM
milrinone to prevent germinal vesicle (GV) breakdown. Oocytes were matured in vitro
in Whitten’s medium (Whitten, 1971) containing 0.01% polyvinyl alcohol (PVA)
(Whittens/PVA).
One-cell embryos were collected from eCG- and hCG-primed CF-1 female mice
mated with B6D2F1/J males (Jackson Laboratory) as previously described (Temeles et
al., 1994). Embryos were cultured in KSOM containing amino acids (Ho et al., 1995) for
up to four days in 5% CO2 in air at 37 °C. One-cell, 2-cell, 4-cell, 8-cell, morula, and
blastocysts that developed in vivo were ﬂushed from either oviducts or uteri at 20–21,
41–44, 60–61, 68, 75–77, and 92–96 h post-eCG, respectively. All animal experiments
were approved by the Institutional Animal Use and Care Committee and were
consistent with National Institutes of Health guidelines.
Microinjection of 1-cell embryos was performed essentially as previously
described (Kurasawa et al., 1989). Prior to pronucleus formation, the embryos were
injected with 10 pl of dsRNA using a Picoliter Injector Microinjection System
(Harvard Apparatus, Holliston, MA); the culture medium was bicarbonate-free
Whitten’s medium containing 0.01% PVA and 25 mM Hepes, pH 7.3. Following
microinjection, the embryos were cultured in KSOM containing amino acids medium
as described above.
Double-stranded RNA (dsRNA) preparation
Double-stranded RNA was prepared by annealing two complementary RNAs
transcribed by T7 or SP6 polymerase in vitro. cDNA fragments were initially subcloned
into the PCRII vector. Hdac1 dsRNA was a 517 bp fragment prepared using primers
5′-ATCCCTAATGAGCTGCCCTACA-3′ and 5′-ATGGAGAAGATGGGGCTGCAGA-3′. Hdac2
dsRNA was a 560 bp-fragment prepared with 5′-TGTTGCCCGATGTTGGACATAT-3′ and5′-ATCTTATCCCAG AACGTGTCTCAC-3′. Hdac3 dsRNA was a 506 bp-fragment prepared
with 5′-AATACTTCGAGTACTTTGCCCC-3′ and 5′-CCCTGAGAGGGACAATCATC-3′.
After in vitro transcription using T7 and SP6 RNA polymerase (Ambion), DNA
templates were removed by DNase I treatment. The RNA products were extracted with
phenol: chloroform and then precipitated with ethanol. To anneal sense and antisense
RNAs, equimolar quantities of sense and anti-sense RNAwere mixed in annealing buffer
(10 mM Tris, pH 7.4, 0.1 mM EDTA) to a ﬁnal concentration of 2 µM each, heated for
2 min at 94 °C, and then incubated at room temperature for at least 16 h. To remove
unhybridized RNA, the mixture was treated with 2 μg/ml RNaseT1 (Calbiochem, San
Diego, CA) and 1 μg/ml RNaseA (Sigma) for 30 min at 37 °C. The dsRNA products were
extracted with phenol: chloroform and ethanol precipitated, then dissolved in water.
The quality of dsRNA was conﬁrmed by electrophoresis in an agarose gel. Gfp dsRNA
was prepared as previously described (Stein et al., 2003). The dsRNA samples were
diluted to a ﬁnal concentration of 1–2 mg/ml and stored at −80 °C until used.
In vitro transcription assay
BrUTP incorporation assays were performed as previously described (Aoki et al.,
1997). Fluorescence was detected on a Leica TCS SP laser-scanning confocal microscope.
The intensity of ﬂuorescence was quantiﬁed using NIH Image J software (National
institutes of Health) as previously described (Aoki et al., 1997).
Immunostaining of oocytes/eggs/embryos and quantiﬁcation of ﬂuorescence intensity
Oocytes or embryos were ﬁxed in 2% paraformaldehyde in PBS for 20 min at room
temperature, and then permeabilized with 0.2% Triton X-100 in PBS for 10 min.
Immunocytochemical staining was performed by incubating the ﬁxed samples with
primary antibodies for 60 min, followed by secondary antibodies conjugated with Cy5
or FITC for 60 min. Polyclonal antibodies against HDAC1 (Upstate Biotechnology),
hyperacetylated histone H4 (Upstate Biotechnology) and histone H4 acetylated on K5
(Abcam) and monoclonal antibodies against HDAC2 and HDAC3 (Upstate Biotechnol-
ogy, Lake Placid, NY) were diluted 1:200. The DNAwas stained with 1 μM SYTOX Green
(Molecular Probes, Eugene, OR). The cells were then washed and mounted under a
coverslip with gentle compression in VectaShield antibleaching solution (Vector Labs).
Fluorescence was detected on a Leica TCS SP laser-scanning confocal microscope.
For each HDAC (or H4K5) immunostaining, all samples, i.e., oocytes, eggs, and
embryos, were processed simultaneously. For each HDAC (or H4K5) the laser power was
adjusted so that the signal intensity was below saturation for the developmental stage
that displayed the highest intensity and all images were then scanned at that laser
power. Because all images in a developmental series were taken at the same laser power
one can compare signal intensity changes for a given HDAC (or H4K5) with respect to
developmental stage. One cannot, however, compare the signal intensity of different
HDACs at the same developmental stage.
The intensity of ﬂuorescence was quantiﬁed using NIH Image J software. Brieﬂy,
nuclear signal was outlined and mean ﬂuorescence intensity was measured. This same
encircled region was dragged to the cytoplasm of the same cell, and background
ﬂuorescence was measured. The speciﬁc signal was calculated by dividing nuclear
values by cytoplasmic values.
TUNEL labeling assay
TUNEL (TdT-mediated dUTP nick end labeling) assays were carried out with In Situ
Cell Death Detection Kit (Roche Diagnostics, Basel, Switzerland) according to the
manufacture’s instructions.
RNA extraction and real time RT-PCR
Total RNA from 5 to 50 embryos was extracted using the Absolutely RNAMicroprep
Kit (Stratagene, La Jolla, CA). The reverse transcription reaction, primed with random
hexamers, was performed using Superscript II reverse transcriptase (Invitrogen,
Carlsbad, CA) following the manufacturer’s instructions. Total RNA isolated was reverse
transcribed in a 20 µl reaction volume. The resulting cDNA was quantiﬁed by real time
PCR (qRT-PCR). qRT-PCR analysis was performed with the ABI Taqman Assay-on-
demand probe/primer sets for Hdac1, Hdac2, Hdac3, p21Cip1/Waf, Eif1a and other genes
as described previously (Zeng et al., 2004) (Table S1). One embryo equivalent of cDNA
was used for each real-time PCR reaction with a minimum of three replicates as well as
a minus RT and minus template controls for each gene. Unless otherwise stated,
quantiﬁcation was normalized to Ubf and histone H2A mRNA.
Immunoblot analysis
Protein samples from embryos were solubilized in Laemmli sample buffer
(Laemmli, 1970), resolved by SDS-PAGE (10% gel), and transferred to a nitrocellulose
membrane. The membrane was blocked by soaking in Blotto (Tris-buffered saline with
0.1% Tween-20 and 5% non-fat dried milk) for 1.5 h and incubated overnight with the
primary antibody in blocking solution. The membrane was then washed three times
with TBST (Tris-buffered saline with 0.1% Tween-20), incubated with a secondary
antibody conjugated with horseradish peroxidase for 45 min and washed ﬁve times
with TBST. The signal was detected with the ECL Advance Western blotting detection
reagents (Amersham, Piscataway, NJ) following the manufacturer’s recommendations.
Fig.1. Temporal and spatial pattern of HDAC expression during oocytematuration and preimplantation development. (A) Immunocytochemical analysis of HDAC1–3 expression and acetylation state of H4K5. All samples for a given HDACwere
processed for immunocytochemistry together and all images were taken at the same laser power, thereby enabling direct comparison of signal intensities. When possible, oocytes/embryos were processed for more than one protein. The
experiment was conducted
^
3 times and at least 25 oocytes/embryos were analyzed for each sample. Shown are representative examples. (B) Immunoblot analysis of HDAC1–3 expression. All samples for a given HDAC were processed for
immunoblotting together thereby enabling direct comparison of signal intensities. One hundred oocytes/embryos were loaded per lane and the experiment was conducted twice and β-tubulin was used as a loading control. Shown are
representative examples. GVBD, germinal vesicle breakdown; MI, metaphase I; MII, metaphase II.
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Fig. 3. Temporal pattern of expression ofHdac1
^
, 2
^
, and 3. The relative abundance ofHdac1
^
,
2
^
, and 3 transcriptswas determined by qRT-PCR. The experimentwas conducted twice and
the data are expressed as mean±range and are expressed relative to the value obtained for
oocytes. 1C, 1-cell embryo; 2C, 2-cell embryo; 4C, 4-cell embryo; 8C, 8-cell embryo.
113P. Ma, R.M. Schultz / Developmental Biology 319 (2008) 110–120The primary antibodies (HDAC1, HDAC2, HDAC3, β-tubulin and p21Cip1/Waf) were
diluted 1:1000–1:10000 and secondary antibodies were diluted 1:20000. The antibody
towards p21Cip1/Waf was purchased from BD Biosciences (San Jose, CA).
Statistical analysis
Student t-test was used to evaluate the difference between groups, and differences
of pb0.05 were considered signiﬁcant.
Results
Temporal and spatial pattern of HDAC1, 2, and 3 expression during
oocyte maturation and preimplantation development
Prior to conducting studies to address the role of HDAC1 in the
chromatin-mediated repression of transcription that develops during
the 2-cell stage, we ﬁrst characterized the temporal and spatial ex-
pression pattern of HDAC1, 2, and 3. Each HDAC was concentrated in
the nucleus of the fully-grown, GV-intact oocyte. At metaphase I (MI)
and II (MII), however, only HDAC1 was associated with chromosomes
congressed on the metaphase plate (Fig. 1A) and this localization cor-
relatedwith loss of H4K5 acetylation. A decrease in histone acetylation
occurs during oocyte maturation (Kim et al., 2003; Sarmento et al.,
2004) and association of HDAC1with chromosomes implicates HDAC1
as the responsible HDAC. Following fertilization, HDACs 1–3 again
appear in the pronucleus/nucleus. The intensity of HDAC1 nuclear
staining increased until the morula stage but the morula–blastocyst
transition was accompanied by a decrease in staining intensity. The
intensity of HDAC2 nuclear staining displayed a progressive decreaseFig. 2. Localization of HDAC1, 2, and 3 in oocytes. HDAC1 and 2 and HDAC1 and 3 were
detected by immunocytochemistry in the same oocyte; the HDAC1 antibody was raised
in rabbits whereas mouse monoclonal antibodies were used to detect HDAC2 and
HDAC3. Note that whereas HDAC1 and 2 co-localize mainly throughout the nucleo-
plasm, HDAC3 displays a pronounced enrichment around the nucleolus.commencing at the 2-cell stage, whereas the intensity of HDAC3
nuclear staining displayed a progressive decrease during preimplanta-
tion development. Of note is that whereas both HDAC1 and 2 were
localized throughout the nucleoplasm in oocytes, HDAC3was enriched
around the nucleolus, which in turn is surrounded by a ring of
heterchromatin (Fig. 2); a similar nuclear distribution of HDAC1–3was
also observed in preimplantation embryos (data not shown). HDAC3
could therefore be critical for heterochromatin formation and/or
maintenance.
We also assessed changes in the acetylation state of H4K5 to
evaluate developmental changes in chromatin structure. In somatic
cells, acetylation of histone H4 occurs initially on K16, and then on K8
or K12, and ultimately on K5 (Ren et al., 2005; Turner and Fellows,
1989), an order that is also observed in mouse embryonic stem cells
(Keohane et al., 1996). Thus, acetylation of H4K5 reﬂects hyperacety-
lated histone H4, which is strongly correlated with transcriptionally
permissive chromatin (Urnov and Wolffe, 2001). Interestingly, the
staining intensity of H4K5 inversely correlated with the intensity of
HDAC1 nuclear staining (Fig.1A). This correlation suggests that HDAC1
may be the responsible HDAC for changes in acetylation of H4K5.
The temporal pattern of Hdac1–3 expression assessed by qRT-PCR
revealed that Hdac1 is zygotically expressed, conﬁrming our previous
microarray data (Zeng and Schultz, 2005) (Fig. 3). The relative trans-
cript abundance for Hdac1 and Hdac2 was mirrored by the amount of
HDAC protein as determined by immunoblotting (Fig. 1.B); the dec-
rease in the amount of HDAC3 implies that its rate of degradation
exceeds its rate of synthesis during themorula to blastocyst transition.
The decrease in nuclear staining intensity for all three HDACs may
reﬂect either a decrease in antibody accessibility or HDAC transloca-
tion to the cytoplasm, where the large dilution would obscure detect-
ing the signal by immunoﬂuorescence.
RNAi-mediated ablation of HDAC1 results in acetylation of H4K5
The results described above implicate Hdac1 in development of the
transcriptionally repressive state that initiates during the 2-cell stage
(Wiekowski et al., 1993; Davis et al., 1996) and becomes more pro-
nounced with further development (Christians et al., 1994; Henery et
al., 1995). To address the role of HDAC1 in this process, 1-cell embryos
were injected with Hdac1 dsRNA to ablate both maternal and zygotic
Hdac1mRNA; control embryos were injected with Gfp dsRNA. Results
of these experiments demonstrated that Hdac1 mRNA was efﬁciently
targeted—the relative abundance of Hdac1mRNAwas reduced by 80%
for at least 72 h post-injection—and resulted in a decrease in HDAC1
nuclear staining and amount of HDAC1 protein as determined by
immunoblotting (Figs. 4A, B). RNAi-mediated reduction of Hdac1
mRNA, however, resulted in a transient increase in the relative abun-
dance of both Hdac2 (~50%) and Hdac3 (~150%) mRNA 24 h and 48 h
Fig. 4. RNAi-mediated knockdown of Hdac1 mRNA. (A) Early1-cell embryos prior to pronucleus (PN) formation were injected with either Gfp dsRNA (control) or Hdac1 dsRNA and
then cultured for 24 h, 48 h or 72 h, at which time the relative abundance of Hdac1, 2 and 3 transcripts was assayed by qRT-PCR and expressed relative to controls. The experiment
was performed 4 times and the data expressed as mean±SEM. ⁎, pb0.05. (B) The experiment was performed as described in panel A and the relative amount of HDAC1, 2, or 3 was
determined by immunoblot analysis after 72 h of culture. The experiment was performed twice and shown is an immunoblot. (C) The experiment was performed as described in
panel A and the samples processed for immunocytochemical detection of HDAC1, 2, or 3 at the indicated times. (D) The samples in panel C were also processed for simultaneous
detection of HDAC1 and acetylated H4K5 after 72 h of culture. (E) Quantiﬁcation of the ﬂuorescent signal in panel D. The data are expressed as mean±SEM, pb0.05).
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dance (Hdac2 at 24 h and Hdac3 at 48 h) translated into a increase in
the amount of HDAC2 and 3 protein as detected by immunoblotting
and immunocytochemistry (HDAC2 by 48 h and HDAC3 by 72 h) (Figs.
4B, C). Despite the increased amount of HDAC2 and 3 in HDAC1-
depleted embryos, an increase in acetylated H4K5 was observed in
these embryos (Figs. 4D, E). This ﬁnding provides further evidence
that HDAC1 is the HDAC largely responsible for the acetylation statusof H4K5 because increased expression of HDAC2 and 3 did not com-
pensate for loss of HDAC1.
HDAC1 depletion leads to delayed preimplantation development and
increased p21Cip1/Waf expression
Although depleting HDAC1 by RNAi had little or no effect on dev-
elopment to the compacted 8-cell/morula stage, a signiﬁcantly smaller
Fig. 5. Effect of RNAi-mediated reduction of HDAC1 on development. (A) Early1-cell embryos prior to pronucleus (PN) formation were injected with either Gfp dsRNA (control) or
Hdac1 dsRNA and then cultured for 24 h, 48 h, 72 h or 96 h and scored for development. Development to the compacted 8-cell stage was relatively unaffected, whereas development
to the fully expanded blastocyst stage was inhibited. The experiment was performed 5 times and at least 50 embryos were examined for each sample. (B) Quantiﬁcation of
developmental delay following reduction of HDAC1. Data are expressed as mean±SEM, pb0.05.
Fig. 6. Effect of HDAC1 knockdown on p21Cip1/Waf expression. The relative amounts of
p21Cip1/Waf mRNA and protein were determined 72 and 96 h following injection,
respectively. (A) The experiment was performed 4 times and the data (mean±SEM) are
expressed relative to controls. The differences are signiﬁcant, pb0.01. (B) The expe-
riment was performed twice and shown is an immunoblot. β-Tubulin was used as a
loading control.
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(Figs. 5A, B). The developmental delay was not due to an increase in
apoptosis because there was no increase in the incidence of apoptotic
cells as detected by TUNEL in Hdac1 dsRNA-injected embryos when
compared to control Gfp dsRNA-injected embryos (Fig. S1); the num-
ber of TUNEL positive cells was 2.8±1.4 and 2.7±1.6 (mean±SEM) in
control and experimental embryos, respectively. Consistent with this
ﬁnding is that depleting HDAC1 protein did not increase expression of
either the pro-apoptotic Bax or Bcl2 transcripts (Fig. S1).
To gain a better understanding of the basis for the developmental
delay of the HDAC1-depleted embryos, we assayed by qRT-PCR ex-
pression of p21cip1/Waf in these embryos. The rationale for doing so is
that HDAC inhibitors induce expression of p21Cip1/Waf (as well as other
CDK inhibitors) in many cells and tumors, leading to cell cycle arrest
(Marks et al., 2003; Zhu et al., 2004). In addition, induction of p21Cip1/Waf
was observed in Hdac1-deﬁcient embryonic stem cells (Lagger et al.,
2002).We noted a 2.5-fold increase in p21Cip1/WafmRNA level 72 h post-
injection (Fig. 6A), as well as a similar increase in p21CIP1p21Cip1/Waf
protein 96 h post-injection (Fig. 6B).
Hdac1 is involved in development of the transcriptionally repressive
state
The ability of HDAC inhibitors to relieve the requirement for
an enhancer for efﬁcient expression of plasmid-borne reporter genes
(Wiekowski et al., 1993; Henery et al., 1995) and to maintain
expression of endogenous genes that are transiently expressed du-
ring the 2-cell stage (Davis et al., 1996) led to the proposal that a
chromatin-mediated transcriptionally repressive state develops dur-
ing the late two-cell stage. To ascertainwhether expression of Hdac1 is
central to development of the transcriptionally repressive state, we
next analyzed HDAC1-suppressed embryos at the late 2-cell stage in
greater detail.
Zygotes injected with Hdac1 dsRNA were collected 35 h after
injection, a time when the embryos were at the late 2-cell stage. We
ﬁrst examined expression of HDAC1, HDAC2 and HDAC3 using immu-
nocytochemistry and observed that HDAC1 staining was reduced
by 55% compared with control Gfp dsRNA-injected embryos, whereas
there was no signiﬁcant effect on either HDAC2 or HDAC3 (Figs. 7A,
B). In addition, histone H4 became hyperacetylated in these in-
jected embryos (Figs. 7A, B), providing further support that HDAC1
is a major regulator of histone acetylation in the preimplantation
embryo.
We had previously noted that TSA treatment of 2-cell embryos
results in a marked increase in acetylation of H4K5 and a global in-crease in transcription using a transcription run-on assay that moni-
tors BrUTP incorporation (Aoki et al., 1997). The increase in acetylation
of H4K5 is much greater than that observed in HDAC1-depleted em-
bryos. Conducting similar experiments using HDAC1-depleted
embryos, however, did not reveal any signiﬁcant increase in BrUTP
incorporation, i.e., there was no apparent increase in overall trans-
cription (Fig. S2). Nevertheless, analysis of a battery of transcripts in
these HDAC1-depleted late 2-cell embryos revealed that expression of
about half were signiﬁcantly enhanced (Fig. 8). Thus, HDAC1 appears
to regulate expression of a subset of transcripts, which is consistent
with its presence in a subset of transcription complexes (Yang and
Seto, 2003, 2008).
Fig. 7. Effect of RNAi-mediated reduction of Hdac1 mRNA on expression of HDAC1, 2, and 3 and histone acetylation in late 2-cell embryos. (A) Immunocytochemical detection of
HDAC1–3 and hyperacetylated histone H4. Note marked reduction in HDAC1 and enhanced staining for hyperacetylated histone H4 but little effect on HDAC2 and HDAC3. The
experiment was performed 4 times and at least 40 embryos were analyzed for each sample. Shown are representative examples. (B) Quantiﬁcation of the reduction in HDAC1 and
increase in hyperacetylated H4. The data are expressed as mean±SEM and relative to controls. In both cases the differences are signiﬁcant, pb0.05.
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To conﬁrm a speciﬁc role for HDAC1 in modulating the acetylation
status of H4K5 and the development of a transcriptionally repressive
state, we used RNAi to target Hdac2 and Hdac3 transcripts. Among
mammalian class I HDACs (subtypes 1, 2, 3 and 8), HDAC1 and HDAC2
are highly similar, with an overall sequence identity of ~82%, and
found in the ubiquitously expressed mSin3a, NURD/Mi2/NRD, and
CoRest co-repressor complexes (Yang and Seto, 2003, 2008). In vivo,
HDAC1 and HDAC2 display activity within co-repressor complexes,
which is consistent with our observation that HDAC1 and HDAC2 co-
localize in preimplantation embryos (data not shown).Fig. 8. Effect of RNAi-mediated degradation of Hdac1mRNA on expression of selected genes in
relative to controls. That data were normalized to human GAPDH mRNA that added as an eRNAi-mediated targeting of Hdac2 resulted in a marked reduction
in Hdac2 mRNA for at least 72 h post-injection of Hdac2 dsRNA into
zygotes (Fig. 9A). Targeting was speciﬁc in that no effect was observed
on the relative abundance of Hdac1 mRNA. Interestingly, there was a
transient increase in expression of Hdac3 mRNA (Fig. 9A). Immu-
noblotting and immunocytochemical analyses revealed that RNAi-
mediated targeting ofHdac2mRNA resulted in a dramatic reduction in
the amount of HDAC2 protein (Figs. 9B, C). Similar analyses revealed
no apparent effect on the amount of HDAC1 and HDAC3 protein. Thus,
even though there was a transient increase in the relative amount of
Hdac3 mRNA in response to targeting Hdac2 mRNA, this increase did
not result in any observable increase in the amount of HDAC3 protein.late 2-cell embryos (i.e., 35 h post-injection). The data (mean±SEM, n=3) are expressed
xternal control prior to RNA isolation. ⁎, pb0.05.
Fig. 9. Effect of RNAi-mediated reduction of Hdac2 mRNA on Hdac expression. (A) Early1-cell embryos prior to pronucleus (PN) formation were injected with either Gfp dsRNA
(control) or Hdac2 dsRNA and then cultured for 24 h, 48 h or 72 h, at which time the relative abundance of Hdac1, 2, and 3 transcripts was assayed by qRT-PCR and expressed relative
to controls. The experiment was performed 4 times and the data expressed as mean±SEM. ⁎, pb0.05. (B) The experiment was performed as described in A and the relative amount of
HDAC1, 2, or 3 was determined by immunoblot analysis after 72 h. The experiment was performed twice and shown is an immunoblot; β-tubulin was used as a loading control. (C)
The experiment was performed as described in panel A and the samples processed for immunocytochemical detection of HDAC1, 2, or 3 at the indicated times. At least 40 embryos
were analyzed for each sample and shown are representative images.
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preimplantation development. We routinely observed that ~80% of
the Hdac2 dsRNA injected eggs reached the blastocyst stage during
the four-day culture period. A comparable rate of development was
also observed for Gfp dsRNA-injected eggs (Fig. S3A). In addition, the
acetylation state of H4K5 was unaffected, and no increase in the
relative abundance of either Eif1a or p21cip1/WAF mRNA was observed
(Fig. S3B–E); the relative abundance of each of these transcripts was
increased following targeting of Hdac1 mRNA (Fig. 3A). These results
strongly suggest that HDAC2 is not required for preimplantation
development.
Although structurally related to HDAC1 and HDAC2, HDAC3 is
component of the NCoR–SMRT co-repressor complex (Guenther et al.,
2002), which is distinct from co-repressor complexes that typically
containHDAC1 andHDAC2 (Yang and Seto, 2003, 2008).We found that
HDAC3 showed a distribution in preimplantation embryos similar to
that observed in oocytes, i.e., enriched on heterochromatin surround-ing the nucleolus (data not shown). This suggests that HDAC3 may
possess unique roles during mouse early embryogenesis.
RNAi-mediated targeting of Hdac3mRNAwas very efﬁcient but did
not result in any signiﬁcant difference in HDAC3 protein as assessed
by immunocytochemistry (Fig. S4). This stability of HDAC3 precluded
our ability to ascertain whether HDAC3 is critical for preimplantation
development.
TSA treatment preferentially stimulates HDAC1 accumulation
An increase in histone H4 acetylation occurs during the 1-cell stage
(Adenot et al., 1997). Histone acetylation, which persists through mi-
tosis, could serve as molecular memory to mark genes for expression
following entry into interphase. We previously demonstrated (Zeng
and Schultz, 2005) and conﬁrmed in this study that Hdac1 is zygo-
tically expressed. To determine whether histone acetylation may
contribute to the formation of a chromatin structure that underlies
Fig. 10. Effect of TSA treatment on Hdac expression and histone acetylation. (A) Two-cell embryos were incubated in the presence or absence of TSA for the indicated times at which
time the embryos were processed for immunocytochemical detection of HDAC1, 2, and 3 and acetylated H4K5. The experiment was performed twice and a total of 24 embryos for
each treatment group were examined. Shown are representative images. (B) Quantiﬁcation of the effect of TSA treatment on the relative amount of Hdac1mRNAwith respect to time
of TSA treatment; the data are expressed relative to untreated embryos that were cultured for the same length of time as those treated with TSA.
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histone hyperacetylation by a 6 h TSA treatment of early 2-cell
embryos on Hdac1–3 expression. As expected, a 6-h TSA treatment led
to a massive increase in histone acetylation (Fig. 10A). TSA treatment
also led to a dramatic increase in Hdac1 expression as determined by
the amount of HDAC1 protein, which was mainly localized to the
cytoplasm. This increase in the amount of HDAC1 protein was
preceded by an increase in the relative abundance of Hdac1 mRNA
(Fig. 10B). In contrast, there was no apparent effect on either Hdac2 or
Hdac3 expression after a 6-h TSA treatment. A 12-h TSA treatment also
resulted in an increase in HDAC2, but not HDAC3 (Fig. 10A). Thus,
histone acetylation may provide a molecular mark for Hdac1
expression in the 2-cell embryo.
Discussion
Results of experiments reported here strongly implicate HDAC1 as
the HDAC primarily responsible for establishing the steady-state level
of histone acetylation in preimplantation mouse embryos, assuming
that acetylation of H4K5 is a proxy for histone hyperacetylation. This
conclusion is based on (1) qRT-PCR and microarray data indicating
that Hdac1 mRNA is the major Class I Hdac transcript present in the
preimplantation embryo, (2) the inverse relationship between HDAC1
nuclear intensity and the acetylation status of H4K5, (3) RNAi-
mediated reduction in HDAC1 resulting in an increase in acetylation
of H4K5 despite a marked compensatory increase in HDAC2 and
HDAC3, (4) expression of Hdac1, but not Hdac2 and Hdac3, accom-
panying genome activation, and (5) Hdac1 expression, which is
stimulated by histone acetylation in other cell types (Hauser et al.,
2002; Schuettengruber et al., 2003), being most sensitive to histone
hyperacetylation induced by TSA.
Consistent with HDAC1 serving as the major HDAC in preimplanta-
tion mouse embryos are results from a previous study that found amarked reduction in total HDAC activity in HDAC1-deﬁcient embryo-
nic stem cells (Lagger et al., 2002). This decrease in total HDAC activity
occurred despite a compensatory increase in HDAC2 and HDAC3
(Lagger et al., 2002), an increase similar to that we observed following
RNAi-mediated reduction of HDAC1. We also ﬁnd that RNAi-mediated
reduction of HDAC2 has no effect on the acetylation state of H4K5,
further supporting a role for HDAC1 as the major HDAC in preim-
plantation mouse embryos.
Oocyte maturation is accompanied by changes in histone mod-
iﬁcations. Although global levels of the Me(K4)H3, Me(K9)H3 and Ph
(S1)H4/H2A appear unchanged (Sarmento et al., 2004), a decrease in
hyperacetylated H4, Me(R17)H3 and Me(R3)H4 occurs (Endo et al.,
2005; Wang et al., 2006; Kim et al., 2003; Sarmento et al., 2004);
histone deacetylation does not occur during mitosis (Kruhlak et al.,
2001). The maturation-associated decrease in acetylation is due to
HDAC activity and an apparent lack of HAT activity (Kim et al., 2003).
TSA treatment prevents thematuration-associated decrease in histone
acetylation, which results in a decrease in the extent of chromosome
condensation. Reduced chromosome condensation is the likely basis
for the observed increase the incidence of aneuploidy (Akiyama et al.,
2006). Of interest is that histone deacetylation accompanying matu-
ration of oocytes obtained from old mice is less pronounced (Akiyama
et al., 2006) and could contribute to the age-associated increase in
aneuploidy observed in females (Hassold, 1986; Hunt and Hassold,
2002). We also noted a maturation-associated decrease in H4K5 ace-
tylation and our ﬁnding that HDAC1, but not HDAC2 or HDAC3, is
associated with condensed chromosomes at MI and MII strongly
suggests that HDAC1 mediates this decrease. Curiously, although
porcine oocytes display a maturation-associated decrease in histone
acetylation, HDAC1 is not associated with metaphase chromosomes in
this species (Wang et al., 2006).
Targeted deletion of Hdac1, which results in embryo death post-
implantation (Lagger et al., 2002), leads to increased expression of
119P. Ma, R.M. Schultz / Developmental Biology 319 (2008) 110–120speciﬁc cyclin-dependent kinase inhibitors (p21Cip1/Waf and p27Kip1)
but no increase in apoptosis (Lagger et al., 2002). Enhanced
expression of these genes likely contributes to the decrease in cell
proliferation in Hdac1-deﬁcient ES cells and post-implantation
embryos; up-regulation of p21Cip1Waf and p27Kip1 expression is likely
due to increased histone acetylation of their promoters. In addition,
CDK inhibitors are often induced in cells and tumors exposed to
HDAC inhibitors with cell cycle arrest in the absence of apoptosis
(Marks et al., 2003; Zhu et al., 2004). We ﬁnd that reducing the
amount of Hdac1 mRNA results in a developmental delay/arrest
with the effect becoming most apparent during the 8-cell/morula to
blastocyst transition; this developmental delay/arrest occurs in the
absence of an increase in apoptosis. Up-regulation of p21Cip1/Waf in
Hdac1-deﬁcient embryos may serve as a primary cause for this delay
by increasing cell cycle time.
Our results indicate that HDAC1 is a major contributor to the
development of the transcriptionally repressive state that is super-
imposed on genome activation. The presence of the transcriptionally
repressive state is unmasked by the increased rate of transcription
observed following inducing histone hyperacetylation (Aoki et al.,
1997) and by the observation that an enhancer is no longer required
for efﬁcient expression of plasmid-born reporter genes (Wiekowski et
al., 1993). We observe a progressive decrease in the steady-state
amount of acetylated H4K5 between the 2-cell and morula stages of
development. Given the positive correlation between histone
acetylation and gene expression, the global decrease in histone
acetylation, which correlates well with the decrease in synthesis of
hyperacetylated H4 between the 1-cell and 8-cell stages (Wiekowski
et al., 1997), may underlie the increasing strength of the transcrip-
tionally repressive state that occurs between the 2-cell and morula
stages.
N-terminal histone modiﬁcations (e.g., phosphorylation, methyla-
tion) are interdependent (Jenuwein and Allis, 2001; Strahl, 2000;
Turner, 2002) and a decrease in H3K9 methylation occurs in HDAC1-
deﬁcient ES cells (Lagger et al., 2002). If H3K9methylation is positively
linked to Hdac1 expression in preimplantation embryos, an increase
in H3K9 methylation, which is associated with repression of trans-
cription via binding of heterochromatic protein 1 (HP1) (Lomberk et
al., 2006), could contribute to the strength of the developmentally
acquired transcriptionally repressive state. Interestingly, reducing
HDAC1 resulted in an increase in Hp1b expression, as well as ex-
pression of Yy1, which recruits HDACs 1–3 to mediate its repressive
function (Thomas and Seto, 1999; Yang et al., 1996). Increased
expression of these genes, like that observed for Hdac2 and Hdac3 in
HDAC1-deﬁcient embryos, may represent another attempt mounted
by the preimplantation embryo to initiate development of the
transcriptionally repressive state in the absence of HDAC1. Whether
other histone modiﬁcations that result in repression of transcription
(e.g., methylation of H3K27 via its ability to recruit polycomb repres-
sive complex 1 (PCR1) (Lyko et al., 2006)), occur as a consequence of
depleting HDAC1 was not investigated.
We previously demonstrated that inducing histone hyperacetyla-
tionwith HDAC inhibitors stimulates global transcription in late 2-cell
stage embryos by 60% (Aoki et al., 1997). In contrast, we ﬁnd no
apparent increase in BrUTP incorporation following HDAC1 knock-
down. A likely explanation is that the increase in histone acetylation
observed following treatment with TSA/trapoxin is markedly greater
than that observed following depletion of HDAC1. Consistent with this
difference is that whereas HDAC1-depleted embryos readily develop
to the 4-cell stage, 2-cell embryos treated with HDAC inhibitors fail to
cleave (Ma et al., 2001). Because HDAC1 was knocked down by 55%, it
is possible that total ablation of HDAC1, which would presumably
result in a more pronounced increase in histone acetylation, would
have resulted in an increase in BrUTP incorporation. This is unlikely to
be the case, however, because by the morula stage when HDAC1 is
virtually undetectable, the increase in acetylation of H4K5 stillremains substantially lower than that observed following TSA treat-
ment. Thus, it is unlikely that HDAC1 is a regulator of global trans-
cription, but rather that HDAC1 affects expression of a subset of genes.
This proposal is consistent with (1) the presence of HDAC1 in a subset
of transcription factor complexes (Yang and Seto, 2003, 2008) (2) our
ﬁnding that only a subset of transcripts are up-regulated following
RNAi-mediated reduction of HDAC1 in late 2-cell embryos, and (3)
microarray analysis revealing ~5% of genes up-regulated in Hdac1-
deﬁcient ES cells (Zupkovitz et al., 2006).
In summary, our results provide support for a seminal function for
HDAC1 in preimplantation development by modulating gene expres-
sion. Future studies will address the impact of depleting HDAC1 on
global patterns of gene expression during the course of genome activ-
ation to identify direct and indirect targets essential for development,
as well as HDAC1′s role in oocyte development, which is characterized
by formation of a transcriptionally quiescent state.
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